EIF4EBP1 and endometrial cancer: In endometrial cancer, Darb-Esfahani et al. reported that Ishikawa cells with higher level of p-4E-BP1 is more sensitive to mTOR inhibitor rapamycin, compared with HEC-1A cells with lower level of p-4E-BP1 [25].